Aulos Bioscience
Latest round
- Series A
Last raised
- Jul 2023
Total raised
- $20M
Investors
- 1
About Aulos Bioscience
Founded in 2020 in Larkspur, US, Aulos Bioscience specializes in cancer therapeutics. The founders include Micah Pearlman, Michael Ehlers, and Yanay Ofran, with Aron Knickerbocker serving as CEO.Aulos Bioscience specializes in developing AU-007, an immune-activating monoclonal antibody aimed at enhancing anti-tumor immune responses. AU-007 targets the interaction between interleukin-2 and the CD25 receptor on regulatory T cells, seeking to minimize severe side effects of traditional therapies.Aulos Bioscience generates revenue through the development and potential commercialization of AU-007. The company collaborates with healthcare institutions and clinical research organizations for patient enrollment and data collection during clinical trials.00 mn on July 28, 2023, Aulos Bioscience plans to allocate these resources to further develop AU-007. The company is focused on advancing its product through clinical trials and intends to explore additional markets for its therapies, particularly in North America and Europe, as development progresses.
Who invested in Aulos Bioscience
1 investor across 2 rounds
See all investors in Aulos Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aulos Bioscience
Who invested in Aulos Bioscience?
Aulos Bioscience has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aulos Bioscience raised?
Aulos Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aulos Bioscience last raise money?
Aulos Bioscience's most recent round on record is a Series A, in Jul 2023.
What does Aulos Bioscience do?
Founded in 2020 in Larkspur, US, Aulos Bioscience specializes in cancer therapeutics.
Where is Aulos Bioscience headquartered?
Aulos Bioscience is headquartered in Larkspur, US.
Which VCs invest in companies like Aulos Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aulos Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aulos Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.